But if you continue on the medication at any dose, some degree of supplementation is likely still beneficial
That's their call to make, not something to guess at on your own
Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials
After 46 weeks of treatment: 0.6 mg dose: 6.2% mean body weight reduction 2.4 mg dose: 12.5% mean body weight reduction 3.6 mg dose: 13.2% mean body weight reduction 4.8 mg dose: 14.9% mean body weight reduction (all randomized) 4.8 mg dose: 18.7% mean body weight reduction (completers only) Placebo: 2.8% mean body weight reduction Among completers at the 4.8 mg dose, 68.8% achieved at least 10% weight loss, 67% achieved at least 15%, and 40% achieved at least 20% weight loss
If you're dealing with declining energy, stubborn body fat, slower recovery times, or brain fog, it's time to look beyond conventional solutions
This advice is primarily based on caution due to limited long-term studies on these medications' safety during lactation
